VOLPATO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 961
EU - Europa 825
AS - Asia 372
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 2.234
Nazione #
US - Stati Uniti d'America 961
GB - Regno Unito 232
VN - Vietnam 175
SE - Svezia 172
IT - Italia 124
DE - Germania 113
CN - Cina 86
IN - India 52
SG - Singapore 39
IE - Irlanda 37
FR - Francia 28
RU - Federazione Russa 25
NG - Nigeria 22
BG - Bulgaria 20
TG - Togo 20
EE - Estonia 17
ZA - Sudafrica 17
UA - Ucraina 14
CH - Svizzera 12
CI - Costa d'Avorio 12
BE - Belgio 10
FI - Finlandia 9
JO - Giordania 8
IR - Iran 6
EU - Europa 4
ES - Italia 3
GR - Grecia 3
UZ - Uzbekistan 3
HR - Croazia 2
MK - Macedonia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
LB - Libano 1
NL - Olanda 1
TR - Turchia 1
Totale 2.234
Città #
Southend 219
Dong Ket 156
Chandler 138
Fairfield 115
Ashburn 68
Ann Arbor 56
Houston 53
Wilmington 53
Woodbridge 48
Princeton 44
Seattle 40
Bologna 37
Dublin 37
Singapore 33
Cambridge 32
Beijing 23
Abeokuta 22
Lomé 20
Sofia 20
New York 18
Padova 18
Westminster 18
Medford 15
Nanjing 15
Berlin 14
Mountain View 13
Abidjan 12
Bern 11
Brussels 10
Saint Petersburg 10
Shenyang 10
Bremen 9
Florence 9
Helsinki 9
Santa Clara 9
Amman 8
Boardman 8
Norwalk 6
Redwood City 6
Turin 6
Changsha 5
Hebei 5
Jinan 5
Nanchang 5
San Diego 5
Des Moines 4
Haikou 4
Monmouth Junction 4
Napoli 4
Paris 4
Bühl 3
Falls Church 3
Pianoro 3
Redmond 3
Taizhou 3
Andover 2
Bitola 2
Jiaxing 2
Leawood 2
London 2
Milan 2
Montegaldella 2
Portland 2
Rome 2
Vijayawada 2
Washington 2
Zhengzhou 2
Aarau 1
Albacete 1
Barcelona 1
Brisbane 1
Büdelsdorf 1
Castel Maggiore 1
Cedar Knolls 1
Cesenatico 1
Den Haag 1
Dhaka 1
Duncan 1
Falkenstein 1
Ferrara 1
Forlì 1
Frankfurt Am Main 1
Fremont 1
Hangzhou 1
Hyderabad 1
Kashan 1
Kilburn 1
Kish 1
Kyiv 1
Los Angeles 1
New Delhi 1
Ningbo 1
Olalla 1
Portici 1
Porto Sant'elpidio 1
Pune 1
San Francisco 1
San Giorgio 1
Sassari 1
Somerton 1
Totale 1.565
Nome #
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 182
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 181
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 173
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 124
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 116
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 115
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 111
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up 110
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 109
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 105
SNP array reveals a new deletion of JAK2 in AML patients 104
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 89
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 85
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 85
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 85
null 78
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 78
Gene expression signature of aneuploidy in acute myeloid leukemia 77
Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia 76
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir 56
null 52
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study 48
Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature 37
Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule 29
Totale 2.305
Categoria #
all - tutte 5.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020363 0 19 2 23 39 34 53 54 57 36 29 17
2020/2021427 44 14 6 3 9 17 8 25 39 23 34 205
2021/2022471 22 17 22 50 49 21 14 28 24 51 92 81
2022/2023552 49 77 20 89 53 46 14 34 100 7 37 26
2023/2024161 10 26 7 15 15 51 9 7 7 7 2 5
2024/202562 22 40 0 0 0 0 0 0 0 0 0 0
Totale 2.305